Author: Mark Doerr

Mark Doerr is a principal and senior research analyst at Tech Insider covering medical technology companies with a focus on cardiovascular and related therapeutic technology. Mark leverages his prior experience as the director of marketing and business development at a medical device company, along with an extensive network of physician and industry relationships, to provide a unique perspective on the medtech sector. Prior to joining Tech Insider in 2011 he covered medical technology for four years at Craig-Hallum Capital, and has in total 20 years of financial and medtech industry experience.
FB Nasdaq FB Facebook
Analysis, BioTech, business, Earnings

Trader’s Watch List: ExamWorks, JAKKS Pacific, Inc

Shares of ExamWorks (NYSE: EXAM) jumped to a new all-time high Wednesday, after the provider of independent medical examinations late Tuesday reported a narrowed Q4 net loss that was smaller than expected while revenue topped Street estimates and the company forecast Q1 and 2014 revenue above analysts’ expectations. EXAM was up 17% at $35.76 recently, after hitting the fresh record at $36.85. The company posted … Continue reading Trader’s Watch List: ExamWorks, JAKKS Pacific, Inc

Mark Doerr
FB Nasdaq FB Facebook
Analysis, news, Tech IPO

Panasonic Talks Boost Tesla (NASDAQ:TSLA) Pre-Market

Tesla (NASDAQ:TSLA) is posting gains in early pre-market trade Wednesday, gaining momentum in the wake of reports the company is in talks with Panasonic about investing nearly $1 billion in a battery factory in the U.S. Panasonic said it was considering various options to strengthen its ties with Tesla, according to multiple media reports citing the Japanese newspaper Nikkei. In Other Pre-Market News Offshore drilling … Continue reading Panasonic Talks Boost Tesla (NASDAQ:TSLA) Pre-Market

Mark Doerr
Analysis, Analyst Actions

Notable Analyst Updates – Spectranetics, HSBC, Verizon, New Home Company, Real Page

Sprectranetics (NASDAQ:SPNC) rose 10% and touched a 52-week high after the company said late Monday its trial using laser atherectomy to treat patients suffering from peripheral artery disease (PAD) had achieved statistical endpoints. Separately, Stifel Nicolas repeated its Buy recommendation on the stock and raised its price target to $30 from $24. Spectranetics, a maker of cardiovascular devices, said Monday it expects to submit a … Continue reading Notable Analyst Updates – Spectranetics, HSBC, Verizon, New Home Company, Real Page

Mark Doerr
Services Sector

Restaurant Stocks in the News – BAGL, BBRG

Bravo Brio Restaurant (NASDAQ:BBRG) delivered 4Q13 operating earnings of $0.30 per share. Results were driven by same-store sales of (1.3%) at Bravo and (1.5%) at Brio. Total revenues decreased approximately (5.2%) y/y to $106.1 million, based partially on same-store sales of (1.3%) at Bravo and (1.5%) at Brio. The company opened 4 new Brio during the quarter. Brio and Bravo same-store sales reflect approximately 3.0% … Continue reading Restaurant Stocks in the News – BAGL, BBRG

Mark Doerr
Analysis

NAB Posts Another Strong Quarter

National Australia Bank delivered another solid performance for first-quarter fiscal 2014 with a 7% increase in unaudited cash profit to AUD 1.55 billion, modestly below consensus of AUD 1.58 billion. Earnings for the major bank again benefited from a sharp fall in bad debts, down 23% to AUD 324 million for the quarter. Moderate loan growth and lower net interest margins restricted income growth to … Continue reading NAB Posts Another Strong Quarter

Mark Doerr
Diversified Tech, Tech IPO

Blount Conference Call Clarifies a Few Issues; 2014 Now Looks Like a Transition Year

On Monday, February 10, Blount issued a broad press release lowering its 2013 guidance and offering 2014 guidance that was below the Street expectations. Management held a conference call Tuesday afternoon to explain the results and outlook. Other corporate information was offered as well, including new 2018 targets and an update on the company’s long-term supply agreement with Husqvarna (extended from 2015 to 2017). Blount … Continue reading Blount Conference Call Clarifies a Few Issues; 2014 Now Looks Like a Transition Year

Mark Doerr